Amphiregulin Promotes BAX Inhibition and Resistance to Gefitinib in Non-small-cell Lung Cancers

Molecular resistance mechanisms affecting the efficiency of receptor tyrosine kinase inhibitors such as gefitinib in non-small-cell lung cancer (NSCLC) cells are not fully understood. Amphiregulin (Areg) overexpression has been proposed to predict NSCLC resistance to gefitinib and we have establishe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Busser, Benoît, Sancey, Lucie, Josserand, Véronique, Niang, Carole, Favrot, Marie C, Coll, Jean-Luc, Hurbin, Amandine
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2009
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2839434/
https://ncbi.nlm.nih.gov/pubmed/19826406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2009.226
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares